LONDON, UK: Halma Plc has acquired the TeDan group of companies, comprising the separate companies of TeDan Surgical Innovations, Inc., West Coast Surgical, LLC, Axcess Surgical Innovations, LLC and TeDan Surgical Innovations GmbH.

Headquartered in Houston, Texas and Half Moon Bay, California, USA, TeDan is a global leader in innovative surgical access systems, which it develops, manufactures and supplies to surgeons for use in a range of acute therapeutic procedures.

Its primary market is access systems for spinal surgery, and the USA accounts for the majority of its sales.

The initial cash consideration for TeDan is US$89.1m (approximately £72m), on a cash- and debt-free basis, which will be funded from Halma’s existing facilities. When adjusted for tax benefits with a net present value of approximately US$9.8 million (approximately £8 million), the net initial consideration is approximately US$79.3 million (approximately £64 million).

An additional earn-out consideration of up to US$10.9m (approximately £9m) is payable in cash, based on TeDan’s performance in the period to June 2024.

TeDan’s consolidated unaudited revenue for the 12 months to 31 March 2023 was US$29.2m (approximately £24m), and TeDan has a Return on Sales above the upper end of Halma’s target range of 18-22%. TeDan will be a standalone company in Halma’s Healthcare sector, led by its current management team.

Danny Fishman, Chief Executive Officer of TeDan, commented: “World spending on healthcare is increasing as demand continues to grow, especially as the number of people over 60 has reached more than one billion. For over ten years, TeDan has been at the forefront of surgical access innovation, creating an improved experience for surgeons in the operating room and better outcomes for patients.  Joining Halma will help us to grow and invest in the U.S. and internationally. Together, we share a common purpose of ensuring a healthier future for everyone, every day.”

Marc Ronchetti, Group Chief Executive of Halma, commented: “TeDan further extends the technologies and capabilities of our Healthcare sector in the treatment of patients in acute therapeutic settings. TeDan’s growth is supported by the growing need for surgical treatment as populations age and as lifestyles evolve and by the development of innovative new surgical procedures which improve efficiency and standards of care. We are delighted to welcome the TeDan team to Halma and look forward to working with them to expand their global impact.”

Halma Plc has acquired IZI Medical Products for $153.5 million

Halma Plc agrees to acquire Sewertronics for upto £52 million